Trial · NCT06276127
Oral Bisoprolol Vs IV Diltiazem in Atrial Fibrillation or Flutter With Rapid Ventricular Rate.
NCT06276127, Phase 3, Not yet recruiting, Oman Medical Speciality Board
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Oral Bisoprolol Vs IV Diltiazem in Atrial Fibrillation or Flutter With Rapid Ventricular Rate. Trials, record NCT06276127. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06276127
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Oral Bisoprolol Vs IV Diltiazem in Atrial Fibrillation or Flutter With Rapid Ventricular Rate.
- NCT number
- NCT06276127
- Status
- Not yet recruiting
- Phases
- Phase 3
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Oman Medical Speciality Board
- Conditions
- Atrial Fibrillation With Rapid Ventricular Response, Atrial Flutter With Rapid Ventricular Response
- Interventions
- Oral Bisoprolol, Intravenous Diltiazem
- First posted
- 2024-02-23
- Last updated
- 2025-03-14
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Efficacy Outcome Evaluated by Achieving the Target Heart Rate Reduction | at 60 minutes | The primary efficacy outcome evaluated by achieving a HR\<110 beats per minute or a decrease ≥20% of baseline HR at 60 minutes |
| Primary | Safety Outcome Evaluated by the Presence of serious adverse event | at 60 minutes | The primary safety outcome measures were HR \< 60 bpm and SBP \< 95 mm Hg |
| Secondary | The use of Rescue medication | 60 minutes | Rescue rate control defined as the administration of a supplementary rate control medication after 60 minutes of the initial dose of the interventional drug |
| Secondary | Proportion of patients who required hospitalization | 90 minutes | percentage of individuals within a study who need to be admitted to a hospital for treatment, observation, or further medical care |
| Secondary | ED revisit | First 48 hour from discharge | Number of patient who will revisit ED with symptomatic AF after stabilization and discharge |
| Secondary | Number of Participants Experiencing Treatment-Related Adverse Events | First 48 hour after receive intervention | Any patient experience ( Dizziness, headaches, gastrointestinal symptoms , Worsening of heart failure or pulmonary edema ) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers11
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06276127
GET https://conductscience.org/api/trials/v1/NCT06276127/registered